Latest Breaking News On - Alexis callahan - Page 5 : comparemela.com

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2023 Earnings Call Transcript February 27, 2024 Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.5, expectations were $-0.53. Esperion Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and […]

Hong kongCzech republicBen halladayBenjamin halladaySheldon koenigDaiichi sankyoInstitute for clinicalEconomic reviewChief financial officerPersonal injury lawyersJim cramer was right about theseEsperion therapeuticsFourth quarterBen halladaySheldon koenigAlexis callahan